Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system

National Medical Journal of China

Volumn 92, Issue 43, 2012, Pages 3032-3035

  Yang, Yang ^a   Wu, Wei Ping ^a   Huang, De Hui ^b   Wu, Lei ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NONE

Author keywords

Aquaporin 4; Central nervous system; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FOLLOW UP; GENETIC TRANSFECTION; HIGH RISK PATIENT; HUMAN; IMMUNOFLUORESCENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; PROGNOSIS; SEROLOGY; SPINAL CORD DISEASE;

ADOLESCENT; ADULT; AQUAPORIN 4; AUTOANTIBODIES; CHILD; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; OPTIC NEURITIS; PROGNOSIS; YOUNG ADULT;

EID: 84872249931     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.43.004     Document Type: Article

References (13)

1. Cheng Q, Miao L, Zhang J, et al. Clinical features of patients with multiple sclerosis from a survey in Shanghai, China. Mult Scler, 2008, 14:671-678.
2. Wingerchuk D M, Lennon V A, Pittock S J, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology, 2006, 66: 1485-1489.
3. Lana-Peixoto M A. Devic's neuromyelitis optica: a critical review. Arq Neuropsiquiatr, 2008, 66:120-138.
4. Polman C H, Reingold S C, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol, 2005, 58:840-846.
5. Kurtzke J F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 1983, 33: 1444-1452.
6. Lennon V A, Wingerchuk D M, Kryzer T J, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet, 2004, 364:2106-2112.
7. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain, 2007, 130:1235-1243.
8. Wingerchuk D M, Lennon V A, Lucchinetti C F, et al. The spectrum of neuromyelitis optica. Lancet Neurol, 2007, 6: 805-815.
9. Matiello M, Lennon V A, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology, 2008, 70: 2197-2200.
10. Weinshenker B G, Wingerchuk D M, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol, 2006, 59:566-569.
11. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain, 2007, 130:1206-1223.
12. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry, 2006, 77:1073-1075.
13. Kira J. Neuromyelitis optica and Asian phenotype of multiple sclerosis. Ann N Y Acad Sci, 2008, 1142:58-71.